NAPIGEN

Wilmington, United States Founded: 2016 • Age: 10 yrs
Hybrid crop plants are developed using genome engineering techniques.
Request Access

About NAPIGEN

NAPIGEN is a company based in Wilmington (United States) founded in 2016 by Roger Wyse.. NAPIGEN has raised $8 million across 5 funding rounds from investors including HHS, RA Capital and Grantham Foundation. The company has 13 employees as of December 31, 2024. NAPIGEN offers products and services including Genome Editing Services. NAPIGEN operates in a competitive market with competitors including Corteva Agriscience, Syngenta, Mahyco, Nuziveedu Seeds and Protealis, among others.

  • Headquarter Wilmington, United States
  • Employees 13 as on 31 Dec, 2024
  • Founders Roger Wyse
  • Sectors
    Agriculture
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Napigen, Inc.
Operational Areas
Agriculture → Agricultural Technology & Innovation
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $8 M (USD)

    in 5 rounds

  • Latest Funding Round
    $175 K (USD), Grant

    Jul 01, 2024

  • Investors
    HHS

    & 6 more

  • Employee Count
    13

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of NAPIGEN

NAPIGEN offers a comprehensive portfolio of products and services, including Genome Editing Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Offers tools for editing mitochondrial and chloroplast genomes in research.

People of NAPIGEN
Headcount 1-10
Employee Profiles 4
Employee Profiles
People
Nicole Rummel
Research Scientist
People
Sachie Kimura
Research Fellow

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of NAPIGEN

NAPIGEN has successfully raised a total of $8M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $175 thousand completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Grant — $175,000
  • First Round

    (18 Apr 2018)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2024 Amount Grant - NAPIGEN Valuation

investors

HHS
Jul, 2022 Amount Seed - NAPIGEN Valuation Grantham Foundation , RA Capital Management
Jun, 2022 Amount Grant - NAPIGEN Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in NAPIGEN

NAPIGEN has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, RA Capital and Grantham Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage bioscience entrepreneurs are supported through venture capital.
Founded Year Domain Location
Food and agtech startups are accelerated by THRIVE programs.
Founded Year Domain Location
Early-stage science-driven companies are supported through venture capital investments.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by NAPIGEN

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - NAPIGEN

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Napigen Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of NAPIGEN

NAPIGEN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Corteva Agriscience, Syngenta, Mahyco, Nuziveedu Seeds and Protealis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Manufacturer and supplier of agricultural farm inputs
domain founded_year HQ Location
Crop protection solutions and hybrid seeds are provided for farming.
domain founded_year HQ Location
Agriculture company offering hybrid and open pollinated seeds
domain founded_year HQ Location
Improved crop varieties and hybrids are developed and marketed.
domain founded_year HQ Location
Hybrid field crop seeds are supplied to farmers.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Napigen

Frequently Asked Questions about NAPIGEN

When was NAPIGEN founded?

NAPIGEN was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is NAPIGEN located?

NAPIGEN is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.

Is NAPIGEN a funded company?

NAPIGEN is a funded company, having raised a total of $8M across 5 funding rounds to date. The company's 1st funding round was a Grant of $225K, raised on Apr 18, 2018.

How many employees does NAPIGEN have?

As of Dec 31, 2024, the latest employee count at NAPIGEN is 13.

What does NAPIGEN do?

NAPIGEN was founded in 2016 and is based in Wilmington, United States. Non-GMO hybrid seeds for autogamous cereals are developed by the company to improve crop yields through hybrid vigor. Proprietary hybridization and genome engineering methods are utilized in operations within the agritech sector. Focus is placed on enhancing agricultural productivity without genetic modification.

Who are the top competitors of NAPIGEN?

NAPIGEN's top competitors include Syngenta, Mahyco and Corteva Agriscience.

What products or services does NAPIGEN offer?

NAPIGEN offers Genome Editing Services.

Who are NAPIGEN's investors?

NAPIGEN has 7 investors. Key investors include HHS, RA Capital, Grantham Foundation, Umdf, and MarsBio.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available